Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2026-01-25 @ 12:15 AM
Study NCT ID:
NCT00143559
Status:
COMPLETED
Last Update Posted:
2009-01-29
First Post:
2005-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
Sponsor:
St. Jude Children's Research Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leukemia | View |
| None | Acute Lymphoblastic Leukemia | View |
| None | Acute Myeloid Leukemia | View |
| None | Chronic Myeloid Leukemia | View |
| None | Juvenile Myelomonocytic Leukemia | View |
| None | Myelodysplastic Syndrome | View |
| None | Paroxysmal Nocturnal Hemoglobinuria | View |
| None | Hodgkin's Lymphoma | View |
| None | Non-Hodgkin Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Allogeneic stem cell transplantation | View |
| None | Haploidentical stem cell transplant | View |
| None | Mismatched family member stem cell donor transplant | View |
| None | Bone marrow transplant | View |
| None | High risk hematological malignancies | View |
| None | T-cell depletion methodology | View |
| None | Miltenyi Biotec CliniMACS stem cell selection device | View |